Navigation Links
Aprecia Welcomes Don Wetherhold as Its Chief Executive Officer
Date:11/11/2013

MASON, Ohio, Nov. 11, 2013 /PRNewswire/ -- Aprecia Pharmaceuticals Company ("Aprecia" or "the company") announced today that it has selected Don Wetherhold to serve as the company's next chief executive officer.  Wetherhold previously served as senior vice president, long-term care at Omnicare, Inc.  Prior to his time at Omnicare, Wetherhold was Aprecia's corporate commercialization officer.

"We are thrilled to have Don back at Aprecia, and we look forward to the leadership he will bring to this role," said E. Thomas Arington, Aprecia's chairman.  "Don was instrumental in devising our commercialization strategy at Aprecia.  We are now preparing to file our first product, and we have two additional products in development.  The company is poised for commercial success, and Don's expertise and commitment certainly augment Aprecia's momentum.

"We also know that Don's extensive experience within the healthcare field will serve both him and the company well.  Furthermore, we highly value not only his experience and intelligence but also his character," Arington concluded.

"I'm excited to be back at Aprecia for a number of reasons, not the least of which is the rare opportunity to be the first at something and redefine a market—which is what our breakthrough 3DP product development and manufacturing system has the potential to do," stated Wetherhold.  "Aprecia's technology is being used to enhance the delivery of gold-standard pharmaceutical products, thereby improving treatment adherence for certain patient populations.  The company's vision is to make medicines easier to take, and Aprecia has made great strides toward that vision this past year." 

Wetherhold has 26 years of experience in the healthcare industry, including key management positions and leadership roles at Omnicare, Cardinal Health, Snyder Healthcare Sales, and Solvay Pharmaceuticals.  Prior to his first tenure with Aprecia in 2010, he served as Prasco Laboratories' senior vice president and general manager of Hampton Laine, Prasco's branded pharmaceutical business.

About Aprecia Pharmaceuticals Company – Aprecia is a unique specialty pharmaceutical company built upon an innovative 3DP (three-dimensional printing) technology and manufacturing system.  Aprecia is the first and only company in the world to utilize this technology to develop and manufacture pharmaceutical products at commercial scale. 

CONTACT: Jeff Zurcher
P 513.204.1200


'/>"/>
SOURCE Aprecia Pharmaceuticals Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ALCOR Scientific Inc. Welcomes New COO
2. Hubble Telemedical Welcomes Healthcare Visionary Jonathan Lord, M.D. to Its Board of Directors
3. Cosmetic Dermatology of Orange County Welcomes Worlds Most Advanced Technology for Tattoo Removal
4. Connecticuts CURE network welcomes HLK, its first Chinese member company
5. PurThread Technologies Welcomes Life Sciences Veterans to CEO and Board Positions
6. PharmaRoth Labs Welcomes Two Respected Physicians to Board of Advisors
7. SkelRegen Welcomes Director of Scientific Affairs to Management Team
8. Chesapeake Urology Associates Welcomes Dr. Anup R. Shah
9. Paradigm Spine Welcomes Hallett Mathews, MD, MBA As Its Executive Vice President & Chief Medical Officer
10. Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors
11. Thomson Reuters Welcomes Inova Software to Its Partner Ecosystem for Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
(Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):